Jazz Pharmaceuticals JAZZ Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's interest income?
- Jazz Pharmaceuticals (JAZZ) reported interest income of $23.4M in Q1 2026.
- How has Jazz Pharmaceuticals's interest income changed year-over-year?
- Jazz Pharmaceuticals's interest income decreased by 15.2% year-over-year, from $27.6M to $23.4M.
- What is the long-term trend for Jazz Pharmaceuticals's interest income?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's interest income has grown at a 162.8% compound annual growth rate (CAGR), from $1.8M to $85.8M.
- What does interest income mean?
- Income earned from holding cash and investments.
- How do you interpret interest income?
- An increase suggests higher cash balances or a more favorable interest rate environment, while a decrease may indicate lower cash reserves or declining market rates.
- How does interest income compare across companies?
- Standard across all industries; varies based on the company's cash position and investment strategy.